Activated microglia in dementia with Lewy bodies

Neurology

Volumn 55, Issue 1, 2000, Pages 132-134

  Mackenzie, Ian R A ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TAU PROTEIN; UBIQUITIN;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN REGION; CONTROLLED STUDY; DEMENTIA; HUMAN; HUMAN TISSUE; INFLAMMATORY DISEASE; LEWY BODY; LIMBIC CORTEX; MICROGLIA; NEOCORTEX; NEUROFIBRILLARY TANGLE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0034641287     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.1.132     Document Type: Article

References (10)

1. McGeer PL, Itagaki S, Tago H, McGeer EG. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 1987;79:195-200.
2. McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996;47:425-432.
3. Rogers J, Kirby LC, Hempielman SR, et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 1993;43: 1609-1611.
4. McKeith IG, Galoasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
5. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
6. Gomez-Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT. Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology 1999;53:1284-1291.
7. Samuel W, Alford M, Hofstetter R, Hansen L. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction and synapse density. J Neuropathol Exp Neurol 1997;56:499-508.
8. Lue LF, Brachova L, Civin H, Rogers J. Inflammation, Aβ deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J Neuropathol Exp Neurol 1996;55:1083-1088.
9. Cummings JL. Lewy body disease with dementia: pathophysiology and treatment. Brain Cogn 1995;28:266-280.
10. Oken RJ. Lewy body diseases: possible new directions in prophylaxis and therapy. Med Hypotheses 1996;46:222-224.